Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The Board of Directors of Redsense Medical AB (publ.) has resolved, in accordance with the authorization given by the Annual General Meeting on 6 May 2019, to increase the Company's share capital with SEK 36,589.60 through a directed new share issue.
The new share issue is directed to Gerhard Dal, Modelio Equity AB, and Pong AB. The share price is set to SEK 11.03 under the agreement, which corresponds to a 10 percent discount compared to the volume-weighted average price during the period between 2019-12-03 and 2019-10-23. The amount of the loan offset by the issue is MSEK 4 plus interest.
As the directed issue is carried out, the number of shares in the Company increases from 12,174,914 to 12,540,810. The dilutive effect is approximately 3 percent for existing shareholders.